Carregant...
Pre-protein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide (CADA)
Cyclotriazadisulfonamide (CADA) inhibits the co-translational translocation of human CD4 (huCD4) into the ER lumen in a signal peptide (SP)-dependent way. We propose that CADA binds the nascent huCD4 SP in a folded conformation within the translocon resembling a normally transitory state during tran...
Guardat en:
| Publicat a: | Traffic |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6980386/ https://ncbi.nlm.nih.gov/pubmed/31675144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tra.12713 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|